Clinical Trials Sponsored by PETHEMA (Program for the Study and Treatment of Haematological Malignances)
Total 2 results
-
Wyeth is now a wholly owned subsidiary of PfizerPETHEMA (Program for the Study and Treatment of Haematological Malignances)CompletedLymphoma | Leukemia | Stem Cell Transplantation | Myelodysplasia | Myeloma | Hematological MalignancySpain
-
PENTA FoundationKarolinska Institutet; Centre Hospitalier Universitaire Saint Pierre; Centro... and other collaboratorsActive, not recruitingHIV Infections | Covid19 | Hepatitis C | Tuberculosis Infection